Need Information?
1-866-STLUKES
A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Learn more.
A Phase III Study of Chemotherapy and Chemoradiotherapy with or without Hyper Acute Pancreas (algenpantucel-L) immunotherapy in Subjects with Surgically Resected Pancreatic Cancer
A Phase III Trial of 6 vs. 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
A Phase II Study of Pre-operative Gemcitabine & Erlotinib plus Pancreatectomy & Post-operative Gemcitabine & Erlotinib for patients with Operable Pancreatic Adenocarcinoma
***Are You Concerned About Your Cancer Risk?***
Miners Campus Awards Academic Scholarships
St. Luke's Warren Campus Receives Donation from Auxiliary
"Get Your Tail on the Trail" Kick-Off
More >>